Request Deal Involvement

ARCH Venture Partners led a $270m Series A funding round in Orbital Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Thrust Strategic Communications

pr advisors

Thrust Strategic Communications

1AB

pr advisors

1AB

Cooley

legal advisors

Cooley

or

Principals

NEWPATH PARTNERS

bidder

NEWPATH PARTNERS

ORBITAL THERAPEUTICS

target

ORBITAL THERAPEUTICS

REDMILE GROUP

bidder

REDMILE GROUP

ARCH VENTURE PARTNERS

bidder

ARCH VENTURE PARTNERS

ABU DHABI GROWTH FUND

bidder

ABU DHABI GROWTH FUND

MOORE STRATEGIC VENTURES

bidder

MOORE STRATEGIC VENTURES

A16Z BIO + HEALTH

bidder

A16Z BIO + HEALTH

IGLOBE PARTNERS

bidder

IGLOBE PARTNERS

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

CASDIN CAPITAL

bidder

CASDIN CAPITAL

AGENT CAPITAL

bidder

AGENT CAPITAL

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

RELLIM CAPITAL MANAGEMENT

bidder

RELLIM CAPITAL MANAGEMENT

HERITAGE MEDICAL SYSTEMS

bidder

HERITAGE MEDICAL SYSTEMS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite